Hospital
Long Island Jewish Medical Center
Long Island Jewish Medical Center was paid $8.41M by Medicaid between Jan 2018 and Dec 2024, across 115 billing codes. Its largest line is 99284, emergency room visit (serious) — 26% of everything it billed.
33Billing provider infoLONG ISLAND JEWISH MEDICAL CENTER
VALLEY STREAM, NY 11580
VALLEY STREAM, NY 11580
33aNPI1346603107assigned 03/30/2016
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.41M
24GClaims211,453
24DCodes billed115
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#86 of 231
Median peer was paid$561K
This provider vs. median15×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official CUSACK, MICHELE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,675 | $137K | |
| 2019 | 13,887 | $533K | |
| 2020 | 32,502 | $1.22M | |
| 2021 | 41,362 | $1.70M | |
| 2022 | 40,007 | $1.73M | |
| 2023 | 42,733 | $1.67M | |
| 2024incomplete | 37,287 | $1.42M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 26% | 13,273 | 12,646 | $2.21M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 8,938 | 8,519 | $1.55M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 16% | 7,539 | 7,085 | $1.32M |
| 70450 | Computed tomography, head or brain; without contrast material | 6.8% | 3,521 | 3,459 | $568K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.8% | 2,908 | 2,854 | $484K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.4% | 1,983 | 1,951 | $285K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.8% | 1,406 | 1,374 | $237K |
| 80053 | Comprehensive metabolic panel | 2.7% | 17,068 | 16,086 | $225K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.5% | 1,747 | 1,676 | $210K |
| 36415 | Collection of venous blood by venipuncture | 2.2% | 25,734 | 18,673 | $189K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.4% | 7,529 | 7,159 | $120K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.1% | 565 | 558 | $95K |
103 more codes
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.1% | 3,462 | $94K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 277 | $74K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,345 | $66K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 363 | $55K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,168 | $54K |
| 86901 | <1% | 1,943 | $48K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,288 | $48K |
| 0225U | <1% | 2,213 | $39K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 449 | $36K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,104 | $30K |
| G0378 | Hospital observation service, per hour | <1% | 32 | $29K |
| 86850 | <1% | 1,968 | $29K | |
| 86900 | <1% | 2,018 | $25K | |
| 83880 | <1% | 1,414 | $23K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 279 | $22K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,959 | $20K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 318 | $19K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 63 | $19K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,690 | $16K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,123 | $15K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,625 | $10K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 581 | $9K |
| 96376 | <1% | 622 | $9K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13,253 | $7K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 831 | $7K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 168 | $6K |
| 93970 | <1% | 13 | $6K | |
| 90715 | <1% | 315 | $5K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 892 | $5K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 188 | $5K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 241 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,049 | $5K |
| 85610 | <1% | 4,497 | $5K | |
| 76830 | Ultrasound, transvaginal | <1% | 95 | $4K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 836 | $3K |
| 84484 | <1% | 4,349 | $3K | |
| 81025 | <1% | 1,598 | $3K | |
| J3490 | Unclassified drugs | <1% | 2,150 | $3K |
| 70498 | <1% | 26 | $3K | |
| 85730 | <1% | 3,849 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 207 | $3K |
| 86769 | <1% | 227 | $2K | |
| 36000 | <1% | 134 | $2K | |
| 85027 | <1% | 1,602 | $2K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 12 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,051 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,052 | $2K |
| 84703 | <1% | 5,313 | $2K | |
| 82962 | <1% | 3,245 | $2K | |
| 83690 | <1% | 4,045 | $2K | |
| 83605 | <1% | 2,130 | $2K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 256 | $2K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 43 | $2K |
| 93971 | <1% | 15 | $2K | |
| 81003 | <1% | 5,813 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 30 | $1K |
| 83735 | <1% | 2,229 | $1K | |
| 85379 | <1% | 1,408 | $1K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 91 | $1K |
| 86703 | <1% | 134 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 705 | $912.06 |
| 70486 | <1% | 26 | $851.42 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 37 | $735.92 |
| 82803 | <1% | 37 | $644.78 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 715 | $548.10 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 602 | $459.55 |
| 87040 | <1% | 176 | $401.71 | |
| 87486 | <1% | 44 | $397.98 | |
| 87581 | <1% | 44 | $397.98 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,480 | $389.09 |
| 73630 | <1% | 39 | $286.01 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 246 | $267.19 |
| 82553 | <1% | 267 | $232.96 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 107 | $227.14 |
| 82550 | <1% | 390 | $211.78 | |
| 73562 | <1% | 69 | $209.92 | |
| 73130 | <1% | 82 | $152.09 | |
| 73610 | <1% | 81 | $143.66 | |
| 87186 | <1% | 142 | $131.50 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 47 | $124.96 |
| 87077 | <1% | 67 | $85.79 | |
| 73030 | <1% | 40 | $65.35 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 42 | $48.80 |
| 70496 | <1% | 12 | $46.98 | |
| 81001 | <1% | 93 | $41.21 | |
| J2704 | Injection, propofol, 10 mg | <1% | 13 | $31.50 |
| 87449 | <1% | 20 | $29.90 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 30 | $23.97 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 68 | $13.37 |
| 84132 | <1% | 42 | $10.47 | |
| 86803 | <1% | 15 | $10.10 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 15 | $8.47 |
| 82150 | <1% | 44 | $6.54 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 14 | $2.25 |
| 85018 | 0% | 26 | $0.00 | |
| 82435 | 0% | 27 | $0.00 | |
| 99080 | 0% | 532 | $0.00 | |
| 84295 | 0% | 27 | $0.00 | |
| 87400 | 0% | 20 | $0.00 | |
| 73110 | 0% | 13 | $0.00 | |
| 85014 | 0% | 26 | $0.00 | |
| 82947 | 0% | 15 | $0.00 | |
| 84100 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCUSACK, MICHELE (SENIOR VP & CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.